These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26724169)

  • 1. Evaluation of mid- and long-term efficacy of shunt limiting for hepatic myelopathy after transjugular intrahepatic portosystemic shunt.
    Zhao H; Liu F; Yue Z; Wang L; Fan Z
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):440-6. PubMed ID: 26724169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study.
    Maleux G; Heye S; Verslype C; Nevens F
    J Vasc Interv Radiol; 2007 Aug; 18(8):986-92; quiz 993. PubMed ID: 17675616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of reduced portosystemic flow on hepatic myelopathy in patients with cirrhosis after TIPS].
    Ma FQ; Huang J; Li WZ; Li PJ; Liu MY; Shi W; Xue H
    Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1063-1068. PubMed ID: 36727230
    [No Abstract]   [Full Text] [Related]  

  • 4. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial.
    Perarnau JM; Le Gouge A; Nicolas C; d'Alteroche L; Borentain P; Saliba F; Minello A; Anty R; Chagneau-Derrode C; Bernard PH; Abergel A; Ollivier-Hourmand I; Gournay J; Ayoub J; Gaborit C; Rusch E; Giraudeau B;
    J Hepatol; 2014 May; 60(5):962-8. PubMed ID: 24480619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel endovascular adjustable polytetrafluoroethylene-covered stent for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Weintraub JL; Mobley DG; Weiss ME; Swanson E; Kothary N
    J Vasc Interv Radiol; 2007 Apr; 18(4):563-6. PubMed ID: 17446548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Portosystemic shunt via the left branch of portal vein for the prevention of encephalopathy following transjugular intrahepatic portosystemic shunt].
    Chu J; Sun X; Piao L; Chen Z; Huang H; Lu C; Xu J
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):437-40. PubMed ID: 12502447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy.
    Pereira K; Carrion AF; Martin P; Vaheesan K; Salsamendi J; Doshi M; Yrizarry JM
    Liver Int; 2015 Dec; 35(12):2487-94. PubMed ID: 26332169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of Early Treatment for Patients with Hepatic Myelopathy Secondary to TIPS: A Retrospective Study in Northern China.
    Zhao H; Yue Z; Wang L; Fan Z; He F; Dong X; Liu F
    Sci Rep; 2018 Oct; 8(1):15184. PubMed ID: 30315180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation.
    Charon JP; Alaeddin FH; Pimpalwar SA; Fay DM; Olliff SP; Jackson RW; Edwards RD; Robertson IR; Rose JD; Moss JG
    J Vasc Interv Radiol; 2004 Nov; 15(11):1219-30. PubMed ID: 15525740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): management with L-ornithine-L-aspartate and stent reduction.
    Stadlbauer V; Tauss J; Portugaller HR; Stiegler P; Iberer F; Stauber RE
    Metab Brain Dis; 2007 Mar; 22(1):45-50. PubMed ID: 17165154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of Transjugular Intrahepatic Portosystemic Shunt: Bare Metal Stent/Stent-graft Combination versus Single Stent-graft, a Prospective Randomized Controlled Study with Long-term Patency and Clinical Analysis.
    Wang CM; Li X; Fu J; Luan JY; Li TR; Zhao J; Dong GX
    Chin Med J (Engl); 2016 Jun; 129(11):1261-7. PubMed ID: 27231160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
    Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
    Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Techniques for Transjugular Intrahepatic Portosystemic Shunt Reduction and Occlusion.
    Taylor AG; Kolli KP; Kerlan RK
    Tech Vasc Interv Radiol; 2016 Mar; 19(1):74-81. PubMed ID: 26997091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Riggio O; Nardelli S; Moscucci F; Pasquale C; Ridola L; Merli M
    Clin Liver Dis; 2012 Feb; 16(1):133-46. PubMed ID: 22321469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study.
    Bureau C; Garcia Pagan JC; Layrargues GP; Metivier S; Bellot P; Perreault P; Otal P; Abraldes JG; Peron JM; Rousseau H; Bosch J; Vinel JP
    Liver Int; 2007 Aug; 27(6):742-7. PubMed ID: 17617116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.
    Deng D; Liao MS; Qin JP; Li XA
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):232-6. PubMed ID: 16698582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.